Utah Medical Products Reports Mixed Financial Results

The Utah-based medical firm reports third-quarter income growth despite a double-digit decrease in total sales.

Updated on Oct. 23, 2026 in Corporate Finance

Bold flat-color editorial illustration depicting a single, stylized stainless steel medical catheter, evoking the precision of medical manufacturing. — Utah Medical Products reported a third-quarter net income of $2.787 million, driven by reduced litigation costs despite a 12.1% sales decline. AI Illustration. Upload story photo >

Live Poll

Do you trust the recent financial performance of specialized medical device manufacturers to indicate market stability?

Utah Medical Products reported $8.621 million in third-quarter 2026 sales, representing a 12.1% decrease from prior periods. Despite lower revenue, the company saw net income rise to $2.787 million for the quarter ending September 30, 2026.

Why it matters

The company's financial performance reflects the impact of lower litigation and intangible-asset amortization expenses on operating income. This growth in net income persists even as the firm integrates recent acquisitions and manages significant declines in specific product lines.

Third-quarter diluted GAAP earnings per share reached $0.876, reflecting a 6.8% increase for the firm. Conversely, gross profit fell 13.6% while the Filshie Clip System recorded a 32.7% sales decline.

The players

Utah Medical Products

This Utah-based medical device manufacturer develops and markets a range of specialized products for women's health and neonatal care.

Femcare

A United Kingdom-based subsidiary of Utah Medical Products that specializes in gynecological surgical devices and medical supplies.

Orion Medical Supplies

A medical supply firm acquired by Femcare in late August 2026 to expand the company's product portfolio and market reach.

The details

Operating income rose to $2.795 million during the third quarter, aided by reduced costs related to litigation and intangible-asset amortization. The company also saw a contribution of $619,000 from its acquisition of Orion Medical Supplies, finalized by subsidiary Femcare in late August 2026.

Late August 2026: Femcare completed the acquisition of Orion Medical Supplies.
September 30, 2026: The company closed its third-quarter fiscal period.
October 22, 2026: Utah Medical Products announced the third-quarter financial results.
November 2026: The company plans to file a Form 10-Q.

Market Dynamics

The company continues to follow the standard disclosure schedule required by the SEC's Form 10-Q reporting requirements. This mandatory filing process ensures transparency as the firm navigates ongoing shifts in its international product distribution and corporate acquisitions.

Shareholders should note the 6.8% increase in diluted GAAP earnings per share as a primary indicator of recent profitability. Investors may evaluate how the ongoing integration of Orion Medical Supplies affects future dividend potential and overall share value.

The takeaway

While total sales have decreased, the reduction in specific operational expenses has allowed the firm to maintain positive net income. Stakeholders should monitor whether the acquisition of new entities can offset the recent sales decline in established product lines.